So according to my predictions last week & the actuals I was almost spot on & slightly conservative:-
Rev: up from A$372mil to 498mil, my call $490M (1% difference)
Margin: up from 30m to 102mil, my call $64M (40% higher)
EBITDA: up from 20.5 to 66.2mil, my call $42M (50% higher)
EBIT: up from -26.8m to 25.38, my call $22M (10% diff)
statutory PAT: up from -114 to 18.91 mil, my call +$22M (5% diff)
Cashflow: up from 14.1 to A$94.4 mil, my call +$100Mpa (5% diff)
Shipment: 8.1 MT correct (0% diff)
Av PIO: A$61/t, actual $66 even better (9% diff)
Full Costs/AISC: A$51.75/t, actual 52.30, close to spot on (2% diff)
Debt payments, +$22M extra, none extra, surprising
Profit after Tax 22M (after impairments & writedowns), actual $18.9M, similar (10% diff)
On current IO price, this means a running margin now -
94/0.77 = 122 x0.57=$70 - $52.30 = $17.70 per WMT x 16Mpa=
$283Mpa free cashflow or $24M per month
With annual sales of AUS$996M pa, free cashflow of $283M pa, strong margin of (17.7/52.3) = 34%, lowering costs and surplus cash
One has to compare it to MINRES which has double the sales income, quadruple the cash and no debt with a $2.1B MCap. On this basis AGO ought to be valued at a MCap of $1B triple the current AGO Mcap or 11c
Thats right 11c!
To get there and match MINRES it needs to
- pay off all debt
- increase cash at bank
- increase production at this margin
- lower costs slightly more
AGO can do it and its undervalued, expect a run to 5c again if IO price stays around here.
- Forums
- ASX - By Stock
- AGO
- fair value for AGO
fair value for AGO, page-4
Featured News
Add AGO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online